Ryan C. Heniford/LinkedIn
Oct 14, 2025, 05:26
Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
Ryan C. Heniford, Director of Global Business Development and Technical Marketing at Evonik, shared a post on LinkedIn:
”Today is World Thrombosis Day! A reminder that thrombosis prevention isn’t just about medication, it’s also about smarter medical devices.
That’s where Evonik’s Endexo technology comes in.
It’s an innovative passive surface modification that makes catheter surfaces inherently more biocompatible — no coatings, no drugs, no leaching.
Key benefits at a glance:
- Up to 99 % reduction in thrombus accumulation
- Less protein and platelet adhesion → reduced clot risk
- Lower friction for smoother handling and less trauma
- Durable performance because Endexo® is part of the polymer itself
On World Thrombosis Day, it’s worth remembering that every thrombus prevented is a patient protected — and that innovation in materials science plays a crucial role in that.”
Stay updated with Hemostasis Today.
-
Oct 15, 2025, 06:01Nita Radhakrishnan Presented The Collaborative Data on Hemophilia from Indian Centers at MENA Conference 2025
-
Oct 15, 2025, 05:53Chris Miskel Shared An Exciting Sneak Peek of The VBRI expansion at The Versiti Vision Summit
-
Oct 14, 2025, 06:19Kay Sharma: I Feel Incredibly Proud and Honored to Share the Final Agenda for The ISTH Continuing Education Forum
-
Oct 14, 2025, 06:12Murray Adams: Professor Favaloro Presented Talks On The 100-Year History of von Willebrand Disease
-
Oct 14, 2025, 06:10Samuel Nweke on Significance of MPV in a CBC in Diagnosis
-
Oct 15, 2025, 06:02Ming Y Lim on Building A Foundation for Women and Girls With Blood Disorders Clinic of Excellence Model
-
Oct 15, 2025, 05:56Wolfgang Miesbach: A Mim8 Extension Study by Pratima Chowdary's Team Showing Robust Profile in Hemophilia A
-
Oct 15, 2025, 05:52Michael Hadley: A Sober Reminder that Ischemic Heart Disease Remains the #1 Cause of Death Worldwide
-
Oct 14, 2025, 06:13Amaliris Guerra: Driving True Innovation in Preclinical Drug Development Related to Iron-Metabolism and Inflammation is One of My Passions!
-
Oct 14, 2025, 05:30Patrick Hsu: A New DNA Editing Technology Reported In Science Magazine
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 13, 2025, 04:48Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 15, 2025, 05:59Courtney Lawrence: I've Got A Place at American Red Cross for You!
-
Oct 15, 2025, 05:50Patrick Robert Receives Otto Schwarz Award at Plasma Protein Forum 2025
-
Oct 15, 2025, 05:48Bravo Awards 2025 Nominees - For Contributions in Caring For Children With Cancer And Blood Disorders
-
Oct 15, 2025, 05:43Watch ITP Awareness Month Quiz by Rocel C Saputil, Michelle MH Tan and The Team
-
Oct 15, 2025, 01:30ISTH President Pantep Angchaisuksiri's Team Organized A ''Run for Flow'' Event to Mark World Thrombosis Day 2025!
Oct 15, 2025, 05:59
Oct 15, 2025, 05:50